Iboga Retreats vs Medical Clinics

The distinction people are asked to make is between a retreat and a clinic. It is the wrong distinction, because the label is unregulated and tells you nothing. The useful question is what is in the room.

What the sector actually does

There is one empirical study of this, and it is worth reading in detail.

Researchers conducted structured interviews with 49 publicly advertised retreat organisations. An important caveat first, and it cuts both ways: only two of the 49 offered ibogaine. The sample is overwhelmingly ayahuasca and psilocybin. So this does not describe the ibogaine sector. It describes the neighbouring one, and it is the only measurement of its kind.

Washout timelines across the sector ranged from one day to more than six weeks for the same classes of medication. Two religious groups with no licensed or emergency-trained staff relied on sober volunteers in case of emergency.

And two organisations told the researchers something that ought to be quoted whenever a retreat mentions its clinicians: these professionals could not legally practise under their licences in this context.

Why the format fights the drug

Retreats are built around a set of assumptions, and ibogaine violates each one.

A retreat assumes the risk is psychological. Preparation, a safe container, integration. Those are the right tools for a difficult experience. Ibogaine’s lethal risk is not psychological and no amount of holding space touches it.

A retreat assumes the danger announces itself. Someone in distress can be comforted. A prolonged QT interval produces no sensation whatsoever. There is nothing to notice, and the arrhythmia can begin hours after everyone believes the hard part is over.

A retreat assumes the risk ends when the experience does. Published deaths occurred up to 76 hours after dosing. The metabolite has a half-life of one to two days. In documented cases the QT interval took a week to normalise. The ceremony ends long before the drug does.

A retreat is usually somewhere beautiful. Which generally means somewhere far from a hospital. The cardiology guidance says a patient at risk should not be transported off the unit, and that persistent torsades may require pacing, which is a hospital procedure. One man who survived four cardiac arrests needed nine days of hospital and intensive care afterwards. What emergency preparedness means sets out what that requires.

The one number that shows the gap

Set the retreat survey against the best-monitored ibogaine treatment ever published.

In a Dutch university hospital, patients were screened out for cardiac history and electrolyte abnormalities, then given 12-lead ECGs every thirty minutes for twelve hours, continuing to 24. Even so, half of them exceeded a QTc of 500 milliseconds and eight of fourteen needed a magnesium infusion.

That is what it takes to see the problem coming. A three-lead monitor with nobody watching it does not, and neither does a facilitator with a first aid certificate.

What a retreat and a clinic should be asked, identically

The label is not a safeguard, so use the same questions for both.

• Continuous cardiac monitoring, how many leads, and for how many hours?
• Who watches it overnight, and what qualification do they hold?
• Are they licensed in this country, and can they practise here in this role?
• Is there a defibrillator and intravenous magnesium in the building?
• How many minutes to a hospital that can treat an arrhythmia, timed at night?
• Is anyone supervising me under the influence of anything?
• What cardiac conditions would mean you refuse me, and how often do you refuse?

How to evaluate a clinic sets out why none of these can be answered by an accreditation, since none exists.

The commercial picture, for context

A separate census of 298 retreat organisations advertising online found that 21, or 7 per cent, offered ibogaine. Advertised prices across the whole sector ranged from twenty dollars to a hundred and fifty thousand, with one outlier at half a million. Those figures are not broken out by substance, so they do not give an ibogaine price. What it costs covers what can and cannot be established about that.

One of the authors of that census discloses paid consulting for a psychedelic company and in-kind support from a retreat operator, which we note as we would anywhere.

The honest summary

There is nothing wrong with a retreat as a form. For substances whose risks are psychological and short-lived, the format matches the problem.

Ibogaine’s risk is cardiac, invisible, and outlasts the retreat by days. The format does not match the problem, and calling the same building a clinic does not change what is inside it. Ibogaine and the heart is the page that decides this one.